PETCO HEALTH AND WELLNESS CO
WOOFNASDAQ🏆 #2533 by market capEarnings Nov 24US Equity
$2.61▲ $0.10 (+3.98%)
Latest quoteTrack WOOF
Get earnings, price moves & breaking news on Telegram
24h▲ 4.0%
7d▲ 3.0%
14d▲ 9.7%
30d▲ 14.7%
ytd▼ 6.8%
1y▼ 25.2%
🏦Market Cap
$846M
Small Cap
📈Revenue Growth (YoY)
-1.3%
Declining
📊Gross Margin
38.8%
Healthy
💵FCF Margin
5.1%
Moderate
⚖️P/S Ratio
0.1x
Cheap
Otter Score
68
Fair
PETCO HEALTH AND WELLNESS CO
WOOFAnalyst Ratings
Price
$2.61
Total
25
Raised
5
Lowered
6
Avg PT
$3.80
H / L
$4 / $3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Evercore ISI Group | Reiterated | In Line | 2026-09-29 | — | — |
BNP Paribas | Reiterated | Underperform | 2026-09-03 | $2.18 | −16.50% |
Baird | Reiterated | Neutral | 2026-09-03 | — | — |
UBS | Reiterated | Neutral | 2026-09-03 | $4.00 | +53.30% |
Citigroup | Reiterated | Neutral | 2026-06-04 | $4.50 | +72.40% |
Jefferies | Upgraded | Hold → Buy | 2026-03-12 | $4.15 | +59.00% |
RBC Capital | Reiterated | Outperform | 2025-09-03 | $4.00 | +53.30% |
Guggenheim | Reiterated | Neutral | 2025-09-02 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2025-08-29 | $4.00 | +53.30% |
Morgan Stanley | Reiterated | Equal Weight | 2025-06-06 | $3.75 | +43.70% |
Wedbush | Reiterated | Outperform | 2025-03-27 | $5.50 | +110.70% |
Goldman Sachs | Reiterated | Buy | 2025-03-27 | $4.14 | +58.60% |
Needham | Reiterated | Buy | 2024-05-23 | $5.00 | +91.60% |
B of A Securities | Downgraded | Buy → Underperform | 2024-04-02 | — | — |
Gordon Haskett | Reiterated | Hold | 2023-04-28 | — | — |
Credit Suisse | Upgraded | Neutral → Outperform | 2021-08-20 | $28.00 | +972.80% |
Benchmark | Downgraded | Buy → Hold | 2017-02-09 | — | — |
CL King | Downgraded | Buy → Neutral | 2017-01-25 | — | — |
Raymond James | Downgraded | Strong Buy → Market Perform | 2017-01-09 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2016-01-20 | — | — |
Stifel | Reiterated | Buy | 2015-07-29 | — | — |
GARP Research | Downgraded | Buy → Neutral | 2014-06-03 | — | — |
Piper Sandler | Upgraded | Neutral → Overweight | 2013-07-25 | — | — |
Northcoast Research | Upgraded | Neutral → Buy | 2013-06-03 | — | — |
Barrington Research | Downgraded | Outperform → Market Perform | 2013-05-19 | — | — |
Institution
Evercore ISI Group
Reiterated · In Line · 2026-09-29
—
—
BNP Paribas
Reiterated · Underperform · 2026-09-03
$2.18
−16.50%
Baird
Reiterated · Neutral · 2026-09-03
—
—
UBS
Reiterated · Neutral · 2026-09-03
$4.00
+53.30%
Citigroup
Reiterated · Neutral · 2026-06-04
$4.50
+72.40%
Jefferies
Upgraded · Hold → Buy · 2026-03-12
$4.15
+59.00%
RBC Capital
Reiterated · Outperform · 2025-09-03
$4.00
+53.30%
Guggenheim
Reiterated · Neutral · 2025-09-02
—
—
Wells Fargo
Reiterated · Equal Weight · 2025-08-29
$4.00
+53.30%
Morgan Stanley
Reiterated · Equal Weight · 2025-06-06
$3.75
+43.70%
Wedbush
Reiterated · Outperform · 2025-03-27
$5.50
+110.70%
Goldman Sachs
Reiterated · Buy · 2025-03-27
$4.14
+58.60%
Needham
Reiterated · Buy · 2024-05-23
$5.00
+91.60%
B of A Securities
Downgraded · Buy → Underperform · 2024-04-02
—
—
Gordon Haskett
Reiterated · Hold · 2023-04-28
—
—
Credit Suisse
Upgraded · Neutral → Outperform · 2021-08-20
$28.00
+972.80%
Benchmark
Downgraded · Buy → Hold · 2017-02-09
—
—
CL King
Downgraded · Buy → Neutral · 2017-01-25
—
—
Raymond James
Downgraded · Strong Buy → Market Perform · 2017-01-09
—
—
William Blair
Upgraded · Market Perform → Outperform · 2016-01-20
—
—
Stifel
Reiterated · Buy · 2015-07-29
—
—
GARP Research
Downgraded · Buy → Neutral · 2014-06-03
—
—
Piper Sandler
Upgraded · Neutral → Overweight · 2013-07-25
—
—
Northcoast Research
Upgraded · Neutral → Buy · 2013-06-03
—
—
Barrington Research
Downgraded · Outperform → Market Perform · 2013-05-19
—
—
One row per institution · price target from the firm's latest published target